By Our Reporter
Global recognition has continued to pour in for Dr. Maduike Ezeibe, for his discovery of a new drug for the cure for HIV/AIDs.
The university don at Michael Okpara University of Agriculture, Umudike in Abia State whose discovery was publicly confirmed by the Vice Chancellor, Prof Francis Otuntai in February has been commended by a combination of American and Chinese scholars for a detailed, concise and scholarly presentation in their journals.
Ezeibe is a professor of Veterinary Medicine and Clinical Virology. The drug was produced with Aluminum Silicate and Magnesium Silicate (Synthetic Aluminum-Magnesium Silicate).
His recent acclaim follows a recent publication of his work by the Scientific Research Publishing, an academic publisher of open access journals.
SCIRP also publishes academic books and conference proceedings and currently has more than 200 open access journals in the areas of science, technology and medicine.
According to Ms Icy Yin, an author assistant of the publication, Ezeibe’s discovery is already impacting the scientific world through his research publication in their medium and they would be grateful to have more from him.
She said: “Thank you very much for your last paper (“Synergy in Antibacterial Activities of Ampicillin Trihydrate, Stabilized with a Synthetic Aluminum-Magnesium Silicate and Immune-Stimulants, on Resistant Escherichia Coli Infection.”) that was published in our journal.
“I am writing to seek papers to this journal. As you know, open access journal is growing rapidly and changing the world. People now can acquire cutting edge research much easier than any time during human history. An open access paper also can get more views and citations during its life circle.
“Do you have any new research manuscripts in hands now? We want more quality journals to be published and shared freely to the world.”
Speaking to Thisage on the development, Ezeibe said: “This is another and even more beneficial use of the Nigerian medicine, recognized. The government should ensure we benefit from our efforts. These other people will take advantage of the secrets already disclosed by the publications while we (Nigeria) lose out.”
Later in the month, Ezeibe would be one of the guest speakers at an international conference on pharmacognosy in Australia as earlier reported by this medium. Organizers of the conference saw the publication of his discovery in other international journals and invited him to come and share his findings with the world.
